Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Endometrial Neoplasms 6 Neoplasms 5 Colonic Neoplasms 4 Squamous Cell Carcinoma of Head and Neck 3 Uterine Cervical Neoplasms 2 Neoplasm Metastasis 2 Vulvar Neoplasms 1 Vaginal Neoplasms 1 Uterine Neoplasms 1 Turcot syndrome 1 Triple Negative Breast Neoplasms 1 Sarcoma 1 Recurrence 1 Rectal Neoplasms 1 Rectal Adenocarcinoma with Mismatch-repair Deficient (dMMR)/ Microsatellite Instability-high (MSI-H) 1 Penile Neoplasms 1 Pathologic Complete Response 1 Pancreatic Neoplasms 1 Ovarian Neoplasms 1 Ovarian Carcinosarcoma 1 Neoplasms, Second Primary 1 Locally Advanced Rectal Cancer (LARC) 1 Hemangiosarcoma 1 Head and Neck Neoplasms 1 Carcinoma, Non-Small-Cell Lung 1 Carcinoma, Neuroendocrine 1 Carcinoma 1 Breast Neoplasms 1 Brain Neoplasms 1 Adrenocortical Carcinoma 1

Interventions

toripalimab 2 pembrolizumab 2 Celecoxib 2 sintilimab 1 dostarlimab 1 camrelizumab 1 Radiation Dose Hypofractionation 1 Nivolumab 1 Neoadjuvant Therapy 1 Ipilimumab 1 Interleukin-2 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × Turcot syndrome × dostarlimab × Clear all

NCT06278857 2024-12-03

SATELLITE

Queensland Centre for Gynaecological Cancer

Phase 2 Recruiting

Turcot syndrome, Endometrial Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡